Xperiment.ca Content References: Heroin · Xperiment.ca Content References: Heroin ... H.B., &...
Transcript of Xperiment.ca Content References: Heroin · Xperiment.ca Content References: Heroin ... H.B., &...
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 2 of 15
Heroin References
Adeniji, A.A., Purcell, A., Pearson, L., Antcliffe, J.M., Tutty, S., Sinha, C., et al. (2010).
Multidisciplinary antenatal care for opiate-using women: Child-care issues. Drug and
Alcohol Review, 29(2), 189–192.
Ahmad, S., Ahmad, H., & Bindra, G. (1989). Cognitive impairment in chronic heroin
addicts. Journal of Personality and Clinical Studies, 5, 237–240.
Alipour, F., Hashemi, H., Piri, N., & Asghari, H. (2010). Ocular manifestations of
transconjunctival heroin abuse: A case report of an unusual route of substance abuse.
Cornea, 29(1), 110–112.
Amir, T., & Bahri, T. (1994). Effect of substance-abuse on visuographic function. Perceptual
and Motor Skills, 78, 235–241.
Awgu, E., Magura, S., & Rosenblum, A. (2010). Heroin-dependent inmates' experiences with
buprenorphine or methadone maintenance. Journal of Psychoactive Drugs, 42(3),
339–346.
Barghi, R.G., & Mirakbari, S.M. (2010). Septic arthritis of sternoclavicular joint: A case
report of a rare finding in injecting drug users. Archives of Iranian Medicine, 13(3),
248–250.
Blanken, P., Hendriks, V.M., van Ree, J.M., & van den Brink, W. (2010). Outcome of long-
term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in
the Netherlands. Addiction (Abingdon, England), 105(2), 300–308.
Blasel, S., Hattingen, E., Adelmann, M., Nichtweiss, M., Zanella, F., & Weidauer, S. (2010).
Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR
imaging and clinical features in three patients. [Toxische leukoenzephalopathie nach
nichtinhalativem heroinabusus. MR-bildgebung und klinischer verlauf bei drei
patienten.] Clinical Neuroradiology, 20(1), 48–53.
Brener, L., von Hippel, W., von Hippel, C., Resnick, I., & Treloar, C. (2010). Perceptions of
discriminatory treatment by staff as predictors of drug treatment completion: Utility
of a mixed methods approach. Drug and Alcohol Review, 29(5), 491–497.
Bruhn, P., & Maage, N. (1975). Intellectual and neuropsychological functions in young men
with heavy and long-term patterns of drug abuse. American Journal of Psychiatry,
132, 397– 401.
Cavanaugh, C.E., Hedden, S.L., & Latimer, W.W. (2010). Sexually transmitted infections
among pregnant heroin- or cocaine-addicted women in treatment: The significance of
psychiatric co-morbidity and sex trade. International Journal of STD & AIDS, 21(2),
141–142.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 3 of 15
Chen, V.C., Lin, T.Y., Lee, C.T., Lai, T.J., Chen, H., Ferri, C.P., et al. (2010). Suicide
attempts prior to starting methadone maintenance treatment in Taiwan. Drug and
Alcohol Dependence, 109(1–3), 139–143.
Chien, C.C., Lin, C.H., Chang, Y.Y., & Lung, F.W. (2010). Association of VNTR
polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in
male Chinese addicts. World Journal of Biological Psychiatry, 11(2 Pt 2), 409–416.
Clatts, M., Giang le, M., Goldsamt, L., & Colon-Lopez, V. (2010). Nonmedical use of
promethazine hydrochloride among heroin injectors in Vietnam: Unrecognized risks
and unintended consequences. Substance Use and Misuse, 45(4), 515–527.
Clatts, M.C., Colon-Lopez, V., Giang le, M., & Goldsamt, L.A. (2010). Prevalence and
incidence of HCV infection among Vietnam heroin users with recent onset of
injection. Journal of Urban Health: Bulletin of the New York Academy of Medicine,
87(2), 278–291.
Comer, S.D., Sullivan, M.A., Vosburg, S.K., Manubay, J., Amass, L., Cooper, Z.D., et al.
(2010). Abuse liability of intravenous buprenorphine/naloxone and buprenorphine
alone in buprenorphine-maintained intravenous heroin abusers. Addiction (Abingdon,
England), 105(4), 709–718.
Comiskey, C.M., & Cox, G. (2010). Analysis of the impact of treatment setting on outcomes
from methadone treatment. Journal of Substance Abuse Treatment, 39(3), 195–201.
Darke, S., Duflou, J., & Torok, M. (2010). The comparative toxicology and major organ
pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol
Dependence, 106(1), 1–6.
Darke, S., Duflou, J., & Torok, M. (2010). Comparative toxicology of intentional and
accidental heroin overdose. Journal of Forensic Sciences, 55, 1015–1018.
Darke, S., Duflou, J., & Torok, M. (2010). A reduction in blood morphine concentrations
amongst heroin overdose fatalities associated with a sustained reduction in street
heroin purity. Forensic Science International, 198(1–3), 118–120.
Darke, S., Ross, J., Mills, K., Teesson, M., Williamson, A., & Havard, A. (2010).
Benzodiazepine use among heroin users: Baseline use, current use and clinical
outcome. Drug and Alcohol Review, 29(3), 250–255.
Darke, S., Torok, M., Kaye, S., Ross, J., & McKetin, R. (2010). Comparative rates of violent
crime among regular methamphetamine and opioid users: Offending and
victimization. Addiction (Abingdon, England), 105(5), 916–919.
Darke, S., Hall, W., Weatherburn, D., & Lind, B. (1999). Fluctuations in heroin purity and
the incidence of fatal heroin overdose. Drug and Alcohol Dependence, 54, 155–161.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 4 of 15
Darke, S., & Zador, D. (1996). Fatal heroin ‘overdose’: A review. Addiction, 91, 1765–1772.
Demetrovics, Z., Varga, G., Szekely, A., Vereczkei, A., Csorba, J., Balazs, H., et al. (2010).
Association between novelty seeking of opiate-dependent patients and the catechol-
O-methyltransferase val(158)met polymorphism. Comprehensive Psychiatry, 51(5),
510–515.
De Vries, T.J., & Shippenberg, T.S. (2002). Neural systems underlying opiate addiction.
Journal of Neuroscience, 22, 3321–3325.
Dickson, A.J., Vorce, S.P., Levine, B., & Past, M.R. (2010). Multiple-drug toxicity caused by
the coadministration of 4-methylmethcathinone (mephedrone) and heroin. Journal of
Analytical Toxicology, 34(3), 162–168.
dos Santos, M.M., Rataemane, S.T., Fourie, D., & Trathen, B. (2010). An approach to heroin
use disorder intervention within the South African context: A content analysis study.
Substance Abuse Treatment, Prevention, and Policy, 5, 13.
Dursteler-MacFarland, K.M., Fischer, D.A., Mueller, S., Schmid, O., Moldovanyi, A., &
Wiesbeck, G.A. (2010). Symptom complaints of patients prescribed either oral
methadone or injectable heroin. Journal of Substance Abuse Treatment, 38(4), 328–
337.
Eiroa-Orosa, F.J., Verthein, U., Kuhn, S., Lindemann, C., Karow, A., Haasen, C., et al.
(2010). Implication of gender differences in heroin-assisted treatment: Results from
the German randomized controlled trial. American Journal on Addictions, 19(4),
312–318.
Elia, D., Marinou, A., & Chetta, A. (2010). Life-threatening asthma after heroin inhalation: A
case report and a review of the literature. Acta Bio Medica: Atenei Parmensis, 81(1),
63–67.
Enoch, M.A., Hodgkinson, C.A., Yuan, Q., Shen, P.H., Goldman, D., & Roy, A. (2010). The
influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin,
and cocaine dependence. Biological Psychiatry, 67(1), 20–27.
Epstein, D.H., Marrone, G.F., Heishman, S.J., Schmittner, J., & Preston, K.L. (2010).
Tobacco, cocaine, and heroin: Craving and use during daily life. Addictive Behaviors,
35(4), 318–324.
Ersche, K.D., Clark, L., London, M., Robbins, T.W., & Sahakian, B.J. (2006). Profile of
executive and memory function associated with amphetamine and opiate dependence.
Neuropsychopharmacology, 31, 1036–1047.
Ersche, K.D., & Sahakian, B.J. (2007). The neuropsychology of amphetamine and opiate
dependence: Implications for treatment. Neuropsychology Review, 17, 317–336.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 5 of 15
Eslami Shahrbabaki, M., Ziaaddini, H., Saieedi, H., & Nakhaiee, N. (2010). Disruptive
behavior disorders in 8 to 14 years old offspring of opium and heroin dependent
parents: A case-control study. Journal of Addiction and Health, 1(2).
Everitt, B.J., & Robbins, T.W. (2005). Neural systems of reinforcement for drug addiction:
from actions to habits to compulsion. Nature Neuroscience, 8, 1481–1489.
Fatovich, D.M., Bartu, A., Davis, G., Atrie, J., & Daly, F.F. (2010). Morbidity associated
with heroin overdose presentations to an emergency department: A 10-year record
linkage study. Emergency Medicine Australasia, 22(3), 240–245.
Fernandez-Serrano, M.J., Perez-Garcia, M., Perales, J.C., & Verdejo-Garcia, A. (2010).
Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in
therapeutic communities. European Journal of Pharmacology, 626(1), 104–112.
Ferri, M., Davoli, M., & Perucci, C.A. (2010). Heroin maintenance for chronic heroin-
dependent individuals. Cochrane Database of Systematic Reviews (Online), 8(8),
CD003410.
Fishbein, D., Krupitsky, E., Flannery, B., Langevin, D.J., Bobashev, G., Verbitskaya, E.,
Augustine, C., Bolla, K., Zvartau, E., Schech, B., Egorova, V., Bushara, N., & Tsoy,
M. (2007). Neurocognitive characterizations of Russian heroin addicts without a
significant history of other drug use. Drug and Alcohol Dependence, 90, 25–38.
Frick, U., Wiedermann, W., Schaub, M., Uchtenhagen, A., & Rehm, J. (2010). Prognostic
factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-
2007]. [Heroingestutzte behandlung in der Schweiz im langzeitverlauf 1994-2007:
Einflussfaktoren auf den behandlungserfolg.] Psychiatrische Praxis, 37(4), 175–182.
Gabilondo, A.M., Meana, J.J., Barturen, F., Sastre, M., & Garcia-Sevilla, J. A. (1994). μ-
Opioid receptor and 2-adrenoceptor agonist binding sites in the postmortem brain of
heroin addicts. Psychopharmacology, 115, 135–140.
Ghaffari, A., Ziaadini, H., & Banazadeh, N. (2010). Comparative evaluation of psychiatric
disorders in opium and heroin dependent patients. Journal of Addiction and Health,
1(1).
Gilman, A.G., Goodman, L.S., Rall, T.W., & Murad, F. (Eds.). (1990). The pharmacological
basis of therapeutics (8th ed.). New Jersey: Pergamon Press.
Greenwald, M.K. (2010). Effects of experimental unemployment, employment and
punishment analogs on opioid seeking and consumption in heroin-dependent
volunteers. Drug and Alcohol Dependence, 111(1–2), 64–73.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 6 of 15
Grigorakos, L., Sakagianni, K., Tsigou, E., Apostolakos, G., Nikolopoulos, G., & Veldekis,
D. (2010). Outcome of acute heroin overdose requiring intensive care unit admission.
Journal of Opioid Management, 6(3), 227–231.
Gruber, S.A., Silveri, M.M., Renshaw, P.F., Tzilos, G.K., Pollack, M., Kaufman, M.J., et al.
(2006). Methadone maintenance improves cognitive performance after two months of
treatment. Experimental and Clinical Psychopharmacology, 14, 157–164.
Gruber, S.A., Silveri, M.M., & Yurgelun-Todd, D.A. (2007). Neuropsychological
consequences of opiate use. Neuropsychology Review, 17, 299–315.
Guerra, D., Sole, A., Cami, J., & Tobena A. (1987). Neuropsychological performance in
opiate addicts after rapid detoxification. Drug and Alcohol Dependence, 20, 261–270.
Gutstein, H.B., & Akil, H. (2005). In L. Brunton, J. Lazo, & K. Parker (Eds.). The
pharmacological basis of theraputics, vol. 1. (pp. 547–590). New York: MacMillan
Publishing Company.
Haasen, C., Verthein, U., Eiroa-Orosa, F.J., Schafer, I., & Reimer, J. (2010). Is heroin-
assisted treatment effective for patients with no previous maintenance treatment?
results from a German randomised controlled trial. European Addiction Research,
16(3), 124–130.
Han, B., Gfroerer, J.C., & Colliver, J.D. (2010). Associations between duration of illicit drug
use and health conditions: Results from the 2005-2007 national surveys on drug use
and health. Annals of Epidemiology, 20(4), 289–297.
Hart, N., Rocha, A., Miller, D.K., & Nation, J.R. (2010). Dose-dependent attenuation of
heroin self-administration with lobeline. Journal of Psychopharmacology (Oxford,
England), 24(1), 51–55.
Hiramatsu, M. (2010). Opium (heroin * morphine). Japanese Journal of Clinical Medicine,
68(8), 1506–1510.
Hulse, G.K., Ngo, H.T., & Tait, R.J. (2010). Risk factors for craving and relapse in heroin
users treated with oral or implant naltrexone. Biological Psychiatry, 68(3), 296–302.
Hyde, S.T. (2010). Global flows in drug treatment: Heroin addiction and therapeutic
community approaches in China. Asia-Pacific Journal of Public Health, 22(3 Suppl),
197S–202S.
Ilic, G., Gligorijevic, J., Milosavljevic, I., & Karadzic, R. (2010). Evaluation of
morphological changes of the liver caused by heroin abuse in forensic practice.
Military-Medical and Pharmaceutical Review, 67(5), 403–410.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 7 of 15
Ilic, G., Karadzic, R., Kostic-Banovic, L., Stojanovic, J., & Antovic, A. (2010).
Ultrastructural changes in the liver of intravenous heroin addicts. Bosnian Journal of
Basic Medical Sciences, 10(1), 38–43.
Iliceto, P., Pompili, M., Girardi, P., Lester, D., Vincenti, C., Rihmer, Z., et al. (2010).
Hopelessness, temperament, and health perception in heroin addicts. Journal of
Addictive Diseases, 29(3), 352–358.
Jaffe, J.H., & Martin, W.R. (1990). Opioid analgesics and antagonists. In A.G. Gilman, T.W.
Rall, A.S. Nies, & P. Taylor (Eds.). The pharmacological basis of therapeutics (8th
ed.) (pp. 485–521). New York: Pergamon Press.
Jian-qiang, R., & Ping, X. (2010). Advancement in heroin dependence and related gene.
Medical Recapitulate.
Kalant, H., LeBlanc, A.E., & Gibbins, R.J. (1971). Tolerance to, and dependence on some
non-opiate psychotropic drugs. Pharmacological Reviews, 23, 135–191.
Kazma, M., Izrael, M., Revel, M., Chebath, J., & Yanai, J. (2010). Survival, differentiation,
and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural
stem cells derived from embryonic stem cells. Journal of Neuroscience Research,
88(2), 315–323.
Kish, S.J. , Kalasinsky, K.S., Derkach, P., Schmunk, G.A., Guttman, M., Ang, L., Adams, V.,
Furukawa, Y., & Haycock, J.W. (2001). Striatal dopaminergic and serotonergic
markers in human heroin users. Neuropsychopharmacology, 24, 561–567.
Kopetz, C.E., Reynolds, E.K., Hart, C.L., Kruglanski, A.W., & Lejuez, C.W. (2010). Social
context and perceived effects of drugs on sexual behavior among individuals who use
both heroin and cocaine. Experimental and Clinical Psychopharmacology, 18(3),
214–220.
Kouros, D., Tahereh, H., Mohammadreza, A., & Minoo, M.Z. (2010). Opium and heroin
alter biochemical parameters of human's serum. American Journal of Drug and
Alcohol Abuse, 36(3), 135–139.
Kovatsi, L., Njau, S., Nikolaou, K., Topouridou, K., Papamitsou, T., & Koliakos, G. (2010).
Evaluation of prooxidant-antioxidant balance in chronic heroin users in a single
assay: An identification criterion for antioxidant supplementation. American Journal
of Drug and Alcohol Abuse, 36(4), 228–232.
Kovatsi, L., Njau, S., Nikolaou, K., Tsolakidou, A., Karamouzis, I., & Thisiadou, K. (2010).
Isoprostane as a marker of oxidative stress in chronic heroin users: Correlation with
duration of heroin use or concomitant hepatitis C infection. American Journal of
Drug and Alcohol Abuse, 36(1), 13–17.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 8 of 15
Krakauer, E.L., Wenk, R., Buitrago, R., Jenkins, P., & Scholten, W. (2010). Opioid
inaccessibility and its human consequences: Reports from the field. Journal of Pain
and Palliative Care Pharmacotherapy, 24(3), 239–243.
Kreek, M.J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of
addiction: Methadone. Journal of Addictive Diseases, 29(2), 200–216.
Lasnier, B., Brochu, S., Boyd, N., & Fischer, B. (2010). A heroin prescription trial: Case
studies from Montreal and Vancouver on crime and disorder in the surrounding
neighbourhoods. International Journal of Drug Policy, 21(1), 28–35.
Lee, T.M., & Pau, C.W. (2002). Impulse control differences between abstinent heroin users
and matched controls. Brain Injury, 16, 885–889.
Lee, T.M.C., Zhou, W.H., Luo, X.J., Yuen, K.S.L., Ruan, X.Z., & Weng, X.C. (2005).
Neural activity associated with cognitive regulation in heroin users: A fMRI study.
Neuroscience Letters, 382, 211–216.
Li, L., Sangthong, R., Chongsuvivatwong, V., Mcneil, E., & Li, J.H. (2010). Lifetime
multiple substance use pattern among heroin users before entering methadone
maintenance treatment clinic in Yunnan, China. Drug and Alcohol Review, 29(4),
420–425.
Litchfield, J., Maronge, A., Rigg, T., Rees, B., Harshey, R., & Keen, J. (2010). Can a
targeted GP-led clinic improve outcomes for street sex workers who use heroin?
British Journal of General Practice, 60(576), 514–516.
Lorenzetti, V., Lubman, D.I., Velakoulis, D., & Yucel, M. (2010). Pituitary gland volume
among heroin users stabilised on substitution pharmacotherapy. Drug and Alcohol
Dependence, 110(1–2), 164–166.
Lu, B., Li, M., Hou, Y.Y., Chen, J., Chi, Z.Q., & Liu, J.G. (2010). Initial experience of
heroin use under a two-chained operant schedule influences drug-seeking behavior
after one month of abstinence. Acta Pharmacologica Sinica, 31(4), 387–392.
Maisto, S.A., Galizio, M., & Connors, G.J. (2008). Drug use and abuse (5th ed.). Belmont,
CA: Wadsworth.
Maldonado, R. (1997). Participation of noradrenergic pathways in the expression of opiate
withdrawal: Biochemical and pharmacological evidence. Neuroscience and
Biobehavioral Reviews, 21, 91–104.
Manning, F.J., & Ingraham, L.H. (1983). Drug ‘overdoses’ among U.S. soldiers in Europe,
1978-1979: Demographics and toxicology. International Journal of the Addictions,
18(2), 153–166.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 9 of 15
Maremmani, I., Stefania, C., Pacini, M., Maremmani, A.G., Carlini, M., Golia, F., et al.
(2010). Differential substance abuse patterns distribute according to gender in heroin
addicts. Journal of Psychoactive Drugs, 42(1), 89–95.
Martin, M., Vanichseni, S., Suntharasamai, P., Mock, P.A., van Griensven, F., Pitisuttithum,
P., et al. (2010). Drug use and the risk of HIV infection amongst injection drug users
participating in an HIV vaccine trial in Bangkok, 1999-2003. International Journal of
Drug Policy, 21(4), 296–301.
Martinova, H., Donchev, T., Milanova, V., & Akiskal, H. (2010). Does heroin addiction
makes temperamental changes? Annals of General Psychiatry, 9(Suppl 1), S141.
Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S.R. (2010).
Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks.
International Journal on Drug Policy, 21(3), 179–185.
Megarbane, B., Buisine, A., Jacobs, F., Resiere, D., Chevillard, L., Vicaut, E., et al. (2010).
Prospective comparative assessment of buprenorphine overdose with heroin and
methadone: Clinical characteristics and response to antidotal treatment. Journal of
Substance Abuse Treatment, 38(4), 403–407.
Mei, W., Zhang, J.X., & Xiao, Z. (2010). Acute effects of sublingual buprenorphine on brain
responses to heroin-related cues in early-abstinent heroin addicts: An uncontrolled
trial. Neuroscience, 170(3), 808–815.
Messinis, L., Andrian, V., Lyros, E., Papathanasiou, T., Panagis, G., & Papathanasopoulos,
P. (2010). P03-234-cognitive functions in buprenorphine maintained patients versus
abstinent heroin abusers on naltrexone hydrochloride therapy. European Psychiatry,
25(S1), 1301.
Mintzer, M.Z., Copersino, M.L., & Stitzer, M.L. (2005). Opioid abuse and cognitive
performance. Drug and Alcohol Dependence, 78, 225–230.
National Institute on Drug Abuse. (2005). Heroin abuse and addiction (NIDA Research
Report Series).
Nielsen, D.A., Hamon, S., Yuferov, V., Jackson, C., Ho, A., Ott, J., et al. (2010). Ethnic
diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of
heroin addicts. Human Genetics, 127(6), 639–649.
Nielsen, D.A., Ji, F., Yuferov, V., Ho, A., He, C., Ott, J., et al. (2010). Genome-wide
association study identifies genes that may contribute to risk for developing heroin
addiction. Psychiatric Genetics, 20, 207–214.
Nordt, C., & Stohler, R. (2010). Combined effects of law enforcement and substitution
treatment on heroin mortality. Drug and Alcohol Review, 29(5), 540–545.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 10 of 15
Nosyk, B., Geller, J., Guh, D.P., Oviedo-Joekes, E., Brissette, S., Marsh, D.C., et al. (2010).
The effect of motivational status on treatment outcome in the North American Opiate
Medication Initiative (NAOMI) study. Drug and Alcohol Dependence, 111(1–2),
161–165.
Nutt, D.J. (2010). Antagonist-agonist combinations as therapies for heroin addiction: Back to
the future? Journal of Psychopharmacology (Oxford, England), 24(2), 141–145.
Oliver, P., Keen, J., Rowse, G., Ewins, E., Griffiths, L., & Mathers, N. (2010). The effect of
time spent in treatment and dropout status on rates of convictions, cautions and
imprisonment over 5 years in a primary care-led methadone maintenance service.
Addiction (Abingdon, England), 105(4), 732–739.
Oppenheimer, E., Tobbutt, G., Taylor, C., & Andrew, T. (1994). Death and survival in a
cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction,
89, 1299–1308.
Ornstein, T.J., Iddon, J.L., Baldacchino, A.M., Sahakian, B.J., London, M., Everitt, B.J., &
Robbins, T.W. (2000). Profiles of cognitive dysfunction in chronic amphetamine and
heroin abusers. Neuropsychopharmacology, 23, 113–26.
Oviedo-Joekes, E., Guh, D., Brissette, S., Marsh, D.C., Nosyk, B., Krausz, M., et al. (2010).
Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of
opioid dependence: A pilot study. Journal of Substance Abuse Treatment, 38(4), 408–
411.
Oviedo-Joekes, E., Guh, D., Brissette, S., Marchand, K., Marsh, D., Chettiar, J., et al. (2010).
Effectiveness of diacetylmorphine versus methadone for the treatment of opioid
dependence in women. Drug and Alcohol Dependence, 111(1–2), 50–57.
Oviedo-Joekes, E., Guh, D., Marsh, D.C., Brissette, S., Nosyk, B., Krausz, M., et al. (2010).
Characteristics and response to treatment among aboriginal people receiving heroin-
assisted treatment. Canadian Journal of Public Health, 101(3), 210–212.
Oviedo-Joekes, E., March, J.C., Romero, M., & Perea-Milla, E. (2010). The Andalusian trial
on heroin-assisted treatment: A 2 year follow-up. Drug and Alcohol Review, 29(1),
75–80.
Pakesch, G., Loimer, N., Grunberger, J., Pfersmann, D., Linzmayer, L., & Mayerhofer, S.
(1992). Neuropsychological findings and psychiatric symptoms in HIV-1 infected and
noninfected drug users. Psychiatry Research, 41, 163–177.
Palepu, A., Marshall, B.D.L., Lai, C., Wood, E., & Kerr, T. (2010). Addiction treatment and
stable housing among a cohort of injection drug users. PLoS One, 5(7), e11697.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 11 of 15
Phillips, K.T., & Stein, M.D. (2010). Risk practices associated with bacterial infections
among injection drug users in Denver, Colorado. American Journal of Drug and
Alcohol Abuse, 36(2), 92–97.
Pong, K.M., Abdel-Latif, M.E., Lui, K., Wodak, A.D., Feller, J.M., Campbell, T., et al.
(2010). The temporal influence of a heroin shortage on pregnant drug users and their
newborn infants in Sydney, Australia. Australian and New Zealand Journal of
Obstetrics and Gynaecology, 50(3), 230–236.
Prosser, J., Cohen, L.J., Steinfeld, M., Eisenberg, D., London, E.D., & Galynker, I.I. (2006).
Neuropsychological functioning in opiate-dependent subjects receiving and following
methadone maintenance treatment. Drug and Alcohol Dependence, 84, 240–247.
Proudnikov, D., Kroslak, T., Sipe, J.C., Randesi, M., Li, D., Hamon, S., et al. (2010).
Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid
amide hydrolase (FAAH) genes with heroin addiction: Impact of long repeats of
CNR1. The Pharmacogenomics Journal, 10(3), 232–242.
Radenkova-Saeva, J., Kostadinova, R., Michova, A., & Petrunov, B. (2010). Pulmonary
complications related to heroin overdose and some changes in immune reactivity.
Central European Journal of Medicine, 5(4), 508–512.
Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C.A., & Haber, P.S. (2010). The
outcome of a rapid hepatitis B vaccination programme in a methadone treatment
clinic. Addiction (Abingdon, England), 105(2), 329–334.
Rapeli, P., Kivisaari, R., Autti, T., Kahkonen, S., Puuskari, V., Jokela, O., & Kalska, H.
(2006). Cognitive function during early abstinence from opioid dependence: A
comparison to age, gender, and verbal intelligence matched controls. BMC
Psychiatry, 6, 9.
Ridenour, T.A., Maldonado-Molina, M., Compton, W.M., Spitznagel, E.L., & Cottler, L.B.
(2005). Factors associated with the transition from abuse to dependence among
substance abusers: Implications for a measure of addictive liability. Drug and Alcohol
Dependence, 80, 1–14.
Risser, D., & Schneider, B. (1994). Drug-related deaths between 1985 and 1992 examined at
the Institute of Forensic Medicine in Vienna, Austria. Addiction, 89, 851–857.
Robins, L.N., Helzer, J.E., Hesselbrock, M., & Wish, E. (2010). Vietnam veterans three years
after Vietnam: How our study changed our view of heroin. American Journal on
Addictions, 19(3), 203–211.
Rounsaville, B.J., Jones, C., Novelly, R.A., & Kleber, H. (1982). Neuropsychological
functioning in opiate addicts. Journal of Nervous and Mental Disease, 170, 209–216.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 12 of 15
Roy, A. (2010). Risk factors for attempting suicide in heroin addicts. Suicide and Life-
Threatening Behavior, 40(4), 416–420.
Salamina, G., Diecidue, R., Vigna-Taglianti, F., Jarre, P., Schifano, P., Bargagli, A.M., et al.
(2010). Effectiveness of therapies for heroin addiction in retaining patients in
treatment: Results from the VEdeTTE study. Substance Use and Misuse, 45(12),
2076–2092.
Salmon, A.M., van Beek, I., Amin, J., Kaldor, J., & Maher, L. (2010). The impact of a
supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction
(Abingdon, England), 105(4), 676–683.
Schulte, B., Schutt, S., Brack, J., Isernhagen, K., Deibler, P., Dilg, C., et al. (2010).
Successful treatment of chronic hepatitis C virus infection in severely opioid-
dependent patients under heroin maintenance. Drug and Alcohol Dependence, 109(1–
3), 248–251.
Seecof, R., & Tennant, F.S. (1986). Subjective perceptions of to the intravenous “rush” of
heroin an cocaine in opiate addicts. American Journal of Drug and Alcohol Abuse,
12, 79–87.
Severtson, S.G., Hedden, S.L., Martins, S.S., & Latimer, W.W. (2012). Patterns of cognitive
impairments among heroin and cocaine users: The association with self-reported
learning disabilities and infectious disease. Journal of Learning Disabilities, 45(2),
139–150.
Severtson, S.G., von Thomsen, S., Hedden, S.L., & Latimer, W. (2010). The association
between executive functioning and motivation to enter treatment among regular users
of heroin and/or cocaine in Baltimore, MD. Addictive Behaviors, 35(7), 717–720.
Sticht, M., Mitsubata, J., Tucci, M., & Leri, F. (2010). Reacquisition of heroin and cocaine
place preference involves a memory consolidation process sensitive to systemic and
intra-ventral tegmental area naloxone. Neurobiology of Learning and Memory, 93(2),
248–260.
Strang, J., Metrebian, N., Lintzeris, N., Potts, L., Carnwath, T., Mayet, S., et al. (2010).
Supervised injectable heroin or injectable methadone versus optimised oral
methadone as treatment for chronic heroin addicts in England after persistent failure
in orthodox treatment (RIOTT): A randomised trial. The Lancet, 375(9729), 1885–
1895.
Strasser, J., Wiesbeck, G.A., Meier, N., Stohler, R., & Dursteler-Macfarland, K.M. (2010).
Effects of a single 50% extra dose of methadone on heroin craving and mood in
lower- versus higher-dose methadone patients. Journal of Clinical
Psychopharmacology, 30(4), 450–454.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 13 of 15
Szczytkowski, J.L., & Lysle, D.T. (2010). Dopamine D(1) receptors within the basolateral
amygdala mediate heroin-induced conditioned immunomodulation. Journal of
Neuroimmunology, 226(1–2), 38–47.
Tang, A.M., Forrester, J.E., Spiegelman, D., Flanigan, T., Dobs, A., Skinner, S., et al. (2010).
Heavy injection drug use is associated with lower percent body fat in a multi-ethnic
cohort of HIV-positive and HIV-negative drug users from three US cities. American
Journal of Drug and Alcohol Abuse, 36(1), 78–86.
Tull, M.T., Gratz, K.L., Aklin, W.M., & Lejuez, C.W. (2010). A preliminary examination of
the relationships between posttraumatic stress symptoms and crack/cocaine, heroin,
and alcohol dependence. Journal of Anxiety Disorders, 24(1), 55–62.
Uchtenhagen, A. (2010). Heroin-assisted treatment in Switzerland: A case study in policy
change. Addiction, 105(1), 29–37.
Van den Oever, M.C., Lubbers, B.R., Goriounova, N.A., Li, K.W., Van der Schors, R.C.,
Loos, M., et al. (2010). Extracellular matrix plasticity and GABAergic inhibition of
prefrontal cortex pyramidal cells facilitates relapse to heroin seeking.
Neuropsychopharmacology, 35(10), 2120–2133.
Verdejo-García, A., Perales, J., & Pérez-García, M. (2007). Cognitive impulsivity in cocaine
and heroin polysubstance abusers. Addictive Behaviors, 32, 950–966.
Verdejo, A., Toribio, I., Orozco, C., Puente, K.L., & Pérez-García, M. (2005).
Neuropsychological functioning in methadone maintenance patients versus abstinent
heroin abusers. Drug and Alcohol Dependence, 78, 283–288.
Villella, C., Iorio, R., Conte, G., Batocchi, A.P., & Bria, P. (2010). Toxic
leukoencephalopathy after intravenous heroin injection: A case with clinical and
radiological reversibility. Journal of Neurology, 257(11), 1924–1926.
Walter, M., Wiesbeck, G.A., Degen, B., Albrich, J., Oppel, M., Schulz, A., et al. (2010).
Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent
patients. Addiction Biology, 16(1), 145–151.
Walter, M., Wiesbeck, G.A., Riecher-Rossler, A., & Borgwardt, S.J. (2010). Neural effects
of heroin: Relation to anxiety stress. Progress in Neuro-Psychopharmacology and
Biological Psychiatry, 34(5), 816–817.
Wang, H., Zhou, J., Huang, L., Li, X., Fennie, K.P., & Williams, A.B. (2010). Effects of
nurse-delivered home visits combined with telephone calls on medication adherence
and quality of life in HIV-infected heroin users in Hunan of China. Journal of
Clinical Nursing, 19(3–4), 380–388.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 14 of 15
Wang, R.F., Tafani, J.A., Frances, B., Bergon, M., Coulais, Y., Zajac, J.M., & Guiraud, R.
(1997). Evaluation of [125I]7α-O-iodoallyl diprenorphine as a new potential SPECT
opioid receptor imaging agent. Nuclear Medicine and Biology, 24, 553–558.
Wang, Z.X., Zhang, J.X., Wu, Q.L., Liu, N., Hu, X.P., Chan, R.C., et al. (2010). Alterations
in the processing of non-drug-related affective stimuli in abstinent heroin addicts.
NeuroImage, 49(1), 971–976.
Warner-Smith, M., Darke, S., Lyndskey, M., & Hall, W. (2001). Heroin overdone: Causes
and consequences. Addiction, 96, 1113–1125.
Wei, W., Ya-rong, W., Wei, Q., Kai, Y., Jie, T., Qiang, L., et al. (2010). Changes in
functional connectivity of ventral anterior cingulate cortex in heroin abusers. Chinese
Medical Journal, 123(12), 1582–1588.
White, J., & Irvine, R. (1999). Mechanisms of fatal opioid overdose. Addiction, 95, 961–972
White, J.M. (2004). Pleasure into pain: The consequences of long-term opioid use. Addictive
Behaviors, 29, 1311–1324.
Wilkins, L., Bissell, P., & Meier, P.S. (2010). Risky injecting practices associated with
snowballing: A qualitative study. Drug and Alcohol Review, 29(3), 256–262.
Workshop, C., & Bird, S.M. (2010). Over 1200 drugs-related deaths and 190,000 opiate-
user-years of follow-up: Relative risks by sex and age group. Addiction Research and
Theory, 18(2), 194–207.
Xiao, L., Wu, Z., Luo, W., & Wei, X. (2010). Quality of life of outpatients in methadone
maintenance treatment clinics. Journal of Acquired Immune Deficiency Syndromes,
53(Suppl 1), S116–120.
Ye, L., Wang, X., Metzger, D.S., Riedel, E., Montaner, L.J., & Ho, W. (2010). Upregulation
of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56
T cells in HCV-infected heroin users. PloS One, 5(3), e9602.
Yeh, Y.W., Lu, R.B., Tao, P.L., Shih, M.C., Lin, W.W., & Huang, S.Y. (2010). Neither
single-marker nor haplotype analyses support an association between the dopamine
transporter gene and heroin dependence in Han Chinese. Genes, Brain, and Behavior,
9(6), 638–647.
Ying, Y., Chenglu, F., Jiang, D., Hanhui, C., & Min, Z. (2010). Gender differences of
temperament and character in heroin dependent patients. Chinese Journal of Drug
Dependence, 19(1), 48–51.
Yongvanitjit, K. (2010). Pulmonary tuberculosis among heroin addicts in Bangkok
metropolitan administration narcotic clinics. Vajira Medical Journal, 51(2), 95–101.
Xperiment.ca Content References: Heroin
© Canadian Centre on Substance Abuse | February 2011 Page 15 of 15
Yuan, K., Qin, W., Dong, M., Liu, J., Liu, P., Zhang, Y., et al. (2010). Combining spatial and
temporal information to explore resting-state networks changes in abstinent heroin-
dependent individuals. Neuroscience Letters, 475(1), 20–24.
Yuan, K., Qin, W., Dong, M., Liu, J., Sun, J., Liu, P., et al. (2010). Gray matter deficits and
resting-state abnormalities in abstinent heroin-dependent individuals. Neuroscience
Letters, 482(2), 101–105.
Yuan, K., Qin, W., Liu, J., Guo, Q., Dong, M., Sun, J., et al. (2010). Altered small-world
brain functional networks and duration of heroin use in male abstinent heroin-
dependent individuals. Neuroscience Letters, 477(1), 37–42.
Yuferov, V., Levran, O., Proudnikov, D., Nielsen, D.A., & Kreek, M.J. (2010). Search for
genetic markers and functional variants involved in the development of opiate and
cocaine addiction and treatment. Annals of the New York Academy of Sciences, 1187,
184–207.
Zhou, L., Lu, B.X., & Yin, J. (2010). Association of cytochrome P4502D6 gene
polymorphism with the susceptibility of heroin spongiform leucoencephalopathy.
Journal of Southern Medical University, 30(3), 572–574, 583.
Zhao, L.Y., Shi, J., Zhang, X.L., Epstein, D.H., Zhang, X.Y., Liu, Y., et al. (2010). Stress
enhances retrieval of drug-related memories in abstinent heroin addicts.
Neuropsychopharmacology, 35(3), 720–726.
Zhao, L.Y., Shi, J., Zhang, X.L., & Lu, L. (2010). Psychosocial stress enhances non-drug-
related positive memory retrieval in male abstinent heroin addicts. Neuroscience
Letters, 485(1), 16–20.
Zhao-sheng, D., Kai-lang, Y., Chen, Z., Yang-ying, Q., & Yong, H. (2010). Comparative
analysis on brain computerized tomography of patients with heroin dependence and
rehabilitation treatments. Journal of Clinical Medicine in Practice, 14(1).
Zunkler, B.J., & Wos-Maganga, M. (2010). Comparison of the effects of methadone and
heroin on human ether-a-go-go-related gene channels. Cardiovascular Toxicology,
10(3), 161–165.
Canadian Centre on Substance Abuse
75 Albert Street, Suite 500 | Ottawa, ON K1P 5E7 | Canada
Phone: 613-235-4048 | Fax: 613-235-8101 | [email protected]